Gabapentin (Neurontin) is not a narcotic or federally controlled substance by the DEA as of November 2022, but it is classified as a Schedule V controlled substance in certain states. Effective: March 12, 2024. Makes amendments to the list of Schedule I, II, and IV controlled substances. Read the bill at: Filed Under: Criminal Tagged With: drugs. INDIANA PRESCRIPTION MONITORING PROGRAM In accordance with Indiana Code IC 35-48-7, the Indiana Board of Pharmacy (Board) has established an electronic prescription drug monitoring program (PMP) for the purpose of compiling records of all scheduled controlled substances dispensed by Indiana pharmacies. Eight states have made gabapentin a schedule V controlled substance. And 12 other states require stricter reporting on gabapentin prescriptions. If you have a prescription for gabapentin, it’s best to take the lowest dose possible. Explore the classification of Gabapentin in Indiana and understand its legal implications, including possession, distribution, and prescription regulations. Gabapentin, a medication initially developed to treat seizures and nerve pain, has seen its use expand significantly in recent years. States are now taking action to track gabapentin use through prescription monitoring programs, and some states have reclassified it as a Schedule V controlled substance. This commentary summarizes gabapentin's abuse potential, identifies state-level actions regarding gabapentin monitoring, and discusses possible clinical implications and ways Please note, this change to statute solely provides for the monitoring and inclusion of Gabapentin in the INSPECT database and does not schedule or affect the prescribing of Gabapentin. For more information and a copy of House Enrolled Act 1246 or House Enrolled Act 1542, please visit the Indiana General Assembly website at iga.in.gov. Gabapentin is approved to treat postherpetic neuralgia and epilepsy with partial-onset seizures. The large majority of gabapentin prescribing is off label. Gabapentin may be abused for euphoria, potentiating the high from opiates, reduction of alcohol cravings, a cocaine-like high, as well as sedation or sleep. Individuals at the highest risk for abusing gabapentin include those with opioid Gabapentin closely resembles pregabalin, a schedule V drug under the Controlled Substances Act in its chemical structure and pharmacological activity. The chemical structure of gabapentin is derived from the addition of a lipophilic cyclohexyl group to the backbone of GABA. In seven states, gabapentin is classified as a schedule V controlled substance (including AL, KY, MI, ND, TN, VA, and WV). Twelve states have not classified gabapentin as a controlled substance, but require gabapentin dispensing must be reported to their PMP (including CT, DC, IN, KS, MA, MN, NE, NJ, OH, OR, UT, and WY). Of those cases, gabapentin was the primary cause of death in 23 individuals. According to this report, gabapentin was amongst one of the . Of the 154 analytes detected, gabapentin accounted for 25 samples. Total exposure calls as a result of gabapentin stayed largely the same between 2017 and in 2017 and 21,423 in 2020. Among cases Discover the current status of gabapentin scheduling as a controlled substance across the US and the PDMP requirements for each state. Valuable insights for healthcare providers. ATTENTION - Effective July 1, 2016, pursuant to IC 35-48-2-8(c)(3), Butalbital, commonly known as Fioricet, is a Schedule III substance in the State of Indiana.As a result, Schedule III requirements in the Indiana Controlled Substances Act and associated administrative rules in 856 IAC 2 apply to its handling and dispensation. As stipulated by IC 25-26-24-17, licensed dispensers throughout Indiana—and out-of-state (non-resident) pharmacies licensed to dispense drugs in Indiana—are required to submit controlled substance prescription data to INSPECT every twenty-four (24) hours. Prescription data submissions must be submitted through the PMP Clearinghouse. Schedule I Drugs: Examples include heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), 3, 4-methylenedioxymethamphetamine (ecstasy), methaqualone, and peyote. Sec. 2.5. As used in this chapter, "controlled substance" has the meaning set forth in IC 35-48-1-9. The term includes gabapentin. As added by P.L.246-2019, SEC.21 and P.L.264-2019, SEC.10. Please note, this change to statute solely provides for the monitoring and inclusion of Gabapentin in the INSPECT database and does not schedule or affect the prescribing of Gabapentin. For more information and a copy of House Enrolled Act 1246 or House Enrolled Act 1542, please visit the Indiana General Assembly website at iga.in.gov. 2020 Indiana Code Title 25. Professions and Occupations Article 26. The term includes gabapentin. As added by P.L.246-2019, SEC.21 and P.L.264-2019, SEC.10. Gabapentin isn't a narcotic, but it is a controlled substance in some states. labeling gabapentin as a Schedule 5 controlled substance. Indiana; Kansas; Massachusetts; Minnesota; Nebraska
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |